BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3372 related articles for article (PubMed ID: 26132597)

  • 41. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience.
    Broeders JA; Ahmed Ali U; Fischer G
    J Am Acad Dermatol; 2016 Aug; 75(2):410-419.e3. PubMed ID: 27177441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topical interventions for genital lichen sclerosus.
    Chi CC; Kirtschig G; Baldo M; Brackenbury F; Lewis F; Wojnarowska F
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008240. PubMed ID: 22161424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.
    Green C; Colquitt JL; Kirby J; Davidson P; Payne E
    Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pimecrolimus: a review of its use in atopic dermatitis.
    Wellington K; Noble S
    Am J Clin Dermatol; 2004; 5(6):479-95. PubMed ID: 15663345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review.
    Zhao S; Hwang A; Miller C; Lio P
    Br J Clin Pharmacol; 2023 Jul; 89(7):2039-2065. PubMed ID: 37075252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TNF-alpha inhibitors for ankylosing spondylitis.
    Maxwell LJ; Zochling J; Boonen A; Singh JA; Veras MM; Tanjong Ghogomu E; Benkhalti Jandu M; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2015 Apr; (4):CD005468. PubMed ID: 25887212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis.
    Fröschl B; Arts D; Leopold C
    GMS Health Technol Assess; 2007 Sep; 3():Doc09. PubMed ID: 21289943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical antifungals for seborrhoeic dermatitis.
    Okokon EO; Verbeek JH; Ruotsalainen JH; Ojo OA; Bakhoya VN
    Cochrane Database Syst Rev; 2015 May; (5):CD008138. PubMed ID: 25933684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical treatments for chronic plaque psoriasis.
    Mason AR; Mason J; Cork M; Dooley G; Hancock H
    Cochrane Database Syst Rev; 2013 Mar; (3):CD005028. PubMed ID: 23543539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interventions for infantile seborrhoeic dermatitis (including cradle cap).
    Victoire A; Magin P; Coughlan J; van Driel ML
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011380. PubMed ID: 30828791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical and device-based treatments for fungal infections of the toenails.
    Foley K; Gupta AK; Versteeg S; Mays R; Villanueva E; John D
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012093. PubMed ID: 31978269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychological and educational interventions for atopic eczema in children.
    Ersser SJ; Cowdell F; Latter S; Gardiner E; Flohr C; Thompson AR; Jackson K; Farasat H; Ware F; Drury A
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD004054. PubMed ID: 24399641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pimecrolimus 1% cream for mild-to-moderate atopic dermatitis: a systematic review and meta-analysis with a focus on children and sensitive skin areas.
    Luger T; Chu CY; Elgendy A; Ibrahim SBBK; Murashkin N; Ranjan S; Zhao Z
    Eur J Dermatol; 2023 Oct; 33(5):474-486. PubMed ID: 38297923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
    Chen SL; Yan J; Wang FS
    J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis.
    Maruani A; Samimi M; Stembridge N; Abdel Hay R; Tavernier E; Hughes C; Le Cleach L
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011541. PubMed ID: 30958563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-TNF agents for paediatric psoriasis.
    Sanclemente G; Murphy R; Contreras J; García H; Bonfill Cosp X
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010017. PubMed ID: 26598969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
    Draelos ZD
    Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral fumaric acid esters for psoriasis.
    Atwan A; Ingram JR; Abbott R; Kelson MJ; Pickles T; Bauer A; Piguet V
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010497. PubMed ID: 26258748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical calcineurin inhibitors in the treatment of atopic dermatitis: a meta-analysis of current evidence.
    Iskedjian M; Piwko C; Shear NH; Langley RG; Einarson TR
    Am J Clin Dermatol; 2004; 5(4):267-79. PubMed ID: 15301573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 169.